您的购物车当前为空
别名 ε-V1-2, Protein Kinase Cɛ Inhibitor Peptide, PKCε Inhibitor Peptide, ɛV1-2, EAVSLKPT
Epsilon-V1-2 是蛋白激酶 C ε(PKCε)的特异性抑制剂。Epsilon-V1-2 被用于卵巢衰老、人颗粒细胞凋亡、脑缺血-再灌注损伤、脑发育、肝细胞胰岛素信号转导以及缺血条件下神经元细胞死亡等相关研究。研究表明,Epsilon-V1-2 能够有效降低 PKCε 的活性,从而促进对线粒体动力学、钙超载、AKT 激活、脑萎缩、胰岛素抵抗及铁死亡等调控通路的深入解析。Epsilon-V1-2 在卒中、SHORT 综合征、肝脂肪变性及脑损伤等疾病模型中显示出显著的治疗相关性。

Epsilon-V1-2 是蛋白激酶 C ε(PKCε)的特异性抑制剂。Epsilon-V1-2 被用于卵巢衰老、人颗粒细胞凋亡、脑缺血-再灌注损伤、脑发育、肝细胞胰岛素信号转导以及缺血条件下神经元细胞死亡等相关研究。研究表明,Epsilon-V1-2 能够有效降低 PKCε 的活性,从而促进对线粒体动力学、钙超载、AKT 激活、脑萎缩、胰岛素抵抗及铁死亡等调控通路的深入解析。Epsilon-V1-2 在卒中、SHORT 综合征、肝脂肪变性及脑损伤等疾病模型中显示出显著的治疗相关性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 μg | ¥ 812 | 现货 | |
| 1 mg | ¥ 1,260 | 现货 | |
| 5 mg | ¥ 5,680 | 现货 | |
| 10 mg | ¥ 10,800 | 现货 |
| 产品描述 | Epsilon-V1-2 has been extensively investigated for its function as a PKC epsilon (PKCε) inhibitor. Epsilon-V1-2 has been widely applied in studies addressing ovarian aging, apoptosis in human granulosa cells, cerebral ischemia-reperfusion injury, brain development, hepatocyte insulin signaling, and neuronal cell death under ischemic conditions. Epsilon-V1-2 has been shown to effectively reduce PKCε activity, thereby enabling detailed exploration of regulatory pathways involving mitochondrial dynamics, calcium overload, AKT activation, brain atrophy, insulin resistance, and ferroptosis. Epsilon-V1-2 demonstrates notable therapeutic relevance in models of stroke, SHORT syndrome, hepatic steatosis, and brain injury, supporting its continued evaluation as a potential pharmacological agent across multiple disease contexts. |
| 体外活性 | Epsilon-V1-2 (1 μM,24 小时) 可显著抑制OA诱导的Cx43 Ser368磷酸化,保护心肌细胞的缝隙连接免受OA诱导的分解[2]。 |
| 体内活性 | Epsilon-V1-2 (20 mg/kg/天,皮下植入0.1 mL渗透泵,每日给药,持续4周)显著改善了移植FVB小鼠心脏的C57BL/6J小鼠心脏的搏动评分 [3]。 |
| 别名 | ε-V1-2, Protein Kinase Cɛ Inhibitor Peptide, PKCε Inhibitor Peptide, ɛV1-2, EAVSLKPT |
| 分子量 | 843.98 |
| 分子式 | C37H65N9O13 |
| CAS No. | 182683-50-7 |
| Smiles | C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCC(O)=O)N)=O)C)=O)[C@H](C)C)=O)CO)=O)CC(C)C)=O)CCCCN)(=O)N1[C@H](C(N[C@@H]([C@@H](C)O)C(O)=O)=O)CCC1 |
| 颜色 | White |
| 物理性状 | Solid |
| Sequence | H-Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr-OH |
| Sequence Short | EAVSLKPT |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100.00 mg/mL (118.49 mM), Sonication is recommended. H2O: ≥ 80 mg/mL, Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多